| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 8, 2023 |
| Accession Number: | 0001193125-23-270410 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 8, 2023 |
| Accession Number: | 0001193125-23-270410 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/25/2023 | $30.00 | Outperform → Mkt Perform | Raymond James |
| 8/18/2023 | $31.00 → $28.00 | Buy → Hold | Truist |
| 8/17/2023 | $29.00 → $27.00 | Sector Outperform → Sector Perform | Scotiabank |
| 8/17/2023 | $31.00 → $29.00 | Overweight → Equal Weight | Wells Fargo |
| 8/3/2023 | $30.00 → $28.00 | Buy → Neutral | Citigroup |
| 8/2/2023 | $30.00 → $28.00 | Neutral → Underweight | JP Morgan |
| 8/2/2023 | $29.00 → $26.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 3/14/2023 | $31.00 → $28.00 | Overweight → Neutral | JP Morgan |
4 - Crestwood Equity Partners LP (0001136352) (Issuer)
4 - Crestwood Equity Partners LP (0001136352) (Issuer)
4 - Crestwood Equity Partners LP (0001136352) (Issuer)